SCHEMBL7262638

SCHEMBL7262638

COc1cc2c(N3CCN(C)CC3)nc(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)nc2c(OC)c1OC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ CYP1A2 P05177 4/20 0.42
▸ TSHR P16473 3/20 0.42
▸ CYP3A4 P08684 3/20 0.42
▸ KDM4E B2RXH2 3/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ CASP1 P29466 1/20 0.42
▸ CASP7 P55210 1/20 0.42
▸ MET P08581 1/20 0.41
▸ ACHE P22303 1/20 0.41
▸ BACE1 P56817 1/20 0.41
▸ NSD2 O96028 1/20 0.40
▸ CYP2D6 P10635 3/20 0.40
▸ MEN1 O00255 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ WHR1 P49842 2/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ USP2 O75604 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7267812 0.89 PIK3CA (0.47) SMN1; SMN2CYP1A2TSHRCYP3A4KDM4E
SCHEMBL5259886 0.79 HPGD (0.40) SMN1; SMN2CYP1A2CYP3A4KDM4EALDH1A1
SCHEMBL5258158 0.78 GAA (0.40) SMN1; SMN2CYP1A2CYP3A4KDM4EALDH1A1
SCHEMBL7262625 0.74 KDM4E (0.60) SMN1; SMN2CYP1A2TSHRCYP3A4KDM4E
SCHEMBL7262055 0.73 TGFBR1 (0.43) SMN1; SMN2TSHRKDM4EALDH1A1HPGD
SCHEMBL7268690 0.72 PDE1B (0.57) SMN1; SMN2TSHRCYP3A4KDM4EALDH1A1
SCHEMBL7261372 0.71 MAPT (0.46) SMN1; SMN2TSHRKDM4EALDH1A1HPGD
SCHEMBL7261507 0.70 ALDH1A1 (0.52) SMN1; SMN2CYP1A2TSHRCYP3A4KDM4E
SCHEMBL7261986 0.70 NPSR1 (0.47) SMN1; SMN2CYP1A2TSHRKDM4EALDH1A1
SCHEMBL7267798 0.70 HTR3E (0.45) SMN1; SMN2CYP1A2TSHRCYP3A4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6613772-B1 Drugs such as 2-(p-chlorophenyl-4-(4-hydroxybutyl)amino-6,7,8 -trimethoxyquinazoline used for activation of guanylate cyclase and modulation of cyclic guanosine monophosphate AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-09-02 — — US disclosed
Send feedback